1.
Clin Case Rep
; 9(2): 853-855, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-985978
ABSTRACT
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.